News

The transformation continues

Start-up founders remain calm despite the challenging financing environment and the uncertain economic situation. Their confidence is bolstered by the fundamental trends that continue to transform the economy and thus create opportunities for innovation.

Mehr auf Startupticker.ch

Positrigo raises CHF 7 million to commercialise its brain imaging device

Positrigo, a Swiss based company developing nuclear medical devices to advance functional brain imaging, closed a new financing round of CHF 7 million. The funds are instrumental to support production and accelerate the commercialization of the NeuroLF system. In addition the ETH spin-off announced the appointment of new board members.

Mehr auf Startupticker.ch

CHF 2.8 million to develop therapies restoring immune balance

SEITO Biologics AG, a preclinical-stage biotechnology company developing novel immunotherapies for autoimmune and chronic-inflammatory diseases, has raised over CHF 2.8 million financed by private investors and the Lichtsteiner Foundation.

Mehr auf Startupticker.ch

Molecular Partners vor Massenentlassung

Das Zürcher Biotech-Unternehmen Molecular Partners plant rund einen Viertel seines 160-köpfigen Teams im Verlaufe des Jahres zu entlassen. Die so angepeilte Kostenreduktion soll bis Anfang 2026 voll wirksam sein und die Fokussierung auf die Weiterentwicklung seiner klinischen Projekte ermöglichen.

Mehr auf Startupticker.ch

Female Founder News #16

As May’s milestones show, the landscape for female founders is evolving—not just through dialogue, but through action, investment, and recognition. 

Mehr auf Startupticker.ch

Un premier lancement clé pour AMP IT à Genève

La startup romande AMP IT vient d'installer son premier « Building as a Grid: Charging 2.0 » à Ideal Park, dans le Canton de Genève. Cette solution optimise la recharge des véhicules électriques en immeubles collectifs tout en renforçant la flexibilité du réseau. Elle combine bornes intelligentes, stockage d’énergie et panneaux solaires pour maximiser…

Mehr auf Startupticker.ch

ZuriEV gets financial boost to scale blood test for brain cancer diagnosis

UZH spin-off ZuriEV has obtained CHF 150,000 from Venture Kick to build its blood-based diagnostic platform for early-stage diagnosis and monitoring of brain cancers. By capturing tumor markers directly from blood, the startup targets a CHF 45 billion global market still dominated by invasive, late-stage diagnostics.

Mehr auf Startupticker.ch

A broad-based initiative for joint Swiss AI innovation

Starting in early September, AI-focused events such as hackathons will take place in more than 10 Swiss cities. Supported by the Federal Government, EPFL AI Center, ETH AI Center, Gebert Rüf Stiftung, Swiss Re, Swisscom, UBS, and more than 55 other organisations, Swiss {ai} Weeks aims to bridge the gap between scientific research and its economic and…

Mehr auf Startupticker.ch

Switzerland Innovation Parks play a key role in Microsoft’s strategic investment initiative

The Switzerland Innovation Parks and Microsoft have announced a new collaboration to accelerate the development and deployment of AI-powered solutions. This initiative - one element of Microsoft’s USD 400 million strategic investment initiative - will be implemented locally through the six Switzerland Innovation Parks that form the Switzerland Innovation…

Mehr auf Startupticker.ch

MassChallenge Switzerland presents 2025 cohort

103 early-stage start-ups have been selected out of more than 1500 applications. 21 companies are from Switzerland.

Mehr auf Startupticker.ch